Physician profile
James M Maher
NPI 1235334145
$6,085.77
in general payments reported to CMS, 2019-2025
33 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $224 · 2021: $993 · 2022: $1,581 · 2023: $1,237 · 2024: $1,064 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,108.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,293.11 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Abiomed | $772.44 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $616.80 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $329.90 | 2021-2025 | Camzyos |
| Penumbra, INC. | $284.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $279.77 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $274.66 | 2020-2024 | Farxiga |
| Edwards Lifesciences Corporation | $213.48 | 2020-2022 | |
| Pfizer INC. | $194.70 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.70 | 2019-2025 | Lifevest |
| Cvrx, INC. | $163.22 | 2022-2025 | Barostim Neo System |
| Cardiva Medical, INC. | $155.87 | 2019-2022 | |
| Atricure, INC. | $149.86 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.81 | 2021-2023 | Jardiance |
| Inspire Medical Systems, INC. | $138.63 | 2023 | Inspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.20 | 2021-2025 | Winrevair, Verquvo |
| Scpharmaceuticals INC. | $125.00 | 2024 | |
| Inari Medical, INC. | $117.35 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $84.06 | 2020-2023 | Repatha |
| Stryker Corporation | $70.56 | 2025 | Flowtriever |
| Acist Medical Systems, INC. | $52.50 | 2024 | |
| Tactile Systems Technology INC | $48.76 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Biotronik INC. | $47.83 | 2021 | |
| Esperion Therapeutics, INC. | $47.02 | 2021 | |
| Alnylam Pharmaceuticals INC. | $39.73 | 2022-2025 | Onpattro |
| Amarin Pharma, INC. | $38.44 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $29.79 | 2024 | |
| Chiesi USA, INC. | $16.08 | 2025 | Curosurf |
| Janssen Pharmaceuticals, INC | $15.98 | 2022 | |
| Cleerly, INC. | $15.91 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Irhythm Technologies, INC. | $15.01 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.74 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.